Melgain (decapeptide)
/ Zydus Lifesci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 07, 2023
The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study.
(PubMed, Cureus)
- "Methods This retrospective analysis utilized data collected from routine clinical practice in the management of vitiligo, focusing on patients treated with topical decapeptide lotion (Melgain™, manufactured by Zydus Healthcare Ltd., Ahmedabad, India)...Both decapeptide regimens, as monotherapy or in combination with other therapies, were effective and well tolerated by most patients. Thus, decapeptide represents a safe and effective therapeutic option for vitiligo treatment."
Journal • Real-world • Real-world evidence • Dermatology • Immunology • Vitiligo • FGF
July 20, 2022
Urology Times Innovation Celebration: Expert Insights - Episode 27: Dr. Crawford on LHRH analogues in prostate cancer
(Urology Times)
- "n this interview, E. David Crawford, MD, discusses the development of luteinizing hormone-releasing hormone agonists and antagonists in prostate cancer."
Interview
1 to 2
Of
2
Go to page
1